Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brincidofovir for Prevention of Adenovirus Disease in HCT Recipients
NCT01241344Phase 2Completed
- Sponsor
- Chimerix Inc.
- Start
- Nov 2010
- Primary completion
- Jun 2013
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of brincidofovir in adenovirus infection, sponsored by Chimerix Inc.. Started Nov 2010; status: completed.
02
Drugs
brincidofovir
03
Conditions
adenovirus infection
Beyond the preview
Go deeper on NCT01241344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01241344.